Job Recruitment Website - Zhaopincom - Announcement on the relocation of COVID-19 inoculation point in Anqiu People's Hospital

Announcement on the relocation of COVID-19 inoculation point in Anqiu People's Hospital

Announcement on the relocation of COVID-19 inoculation point in Anqiu People's Hospital

Dear public friends,

In order to better undertake the vaccination work in COVID-19 for children aged 3-1/kloc-0, the Municipal People's Hospital decided to move the new crown vaccination point from the current site to the 5th floor of the office building of the South Hospital. Therefore, vaccination was suspended from 28th of October to 30th of October in 10/0, and resumed from 30th of October in 10/0. During the period, if there is a need for vaccination in the people's hospital, you can go to other vaccination clinics for vaccination.

Anqiu health bureau

2021101October 27th

Extended content: Who should be vaccinated with COVID-19 vaccine booster?

According to the arrangement of the state and province, the target population of COVID-19 vaccine booster immunization at this stage is 18 years old and above who have been vaccinated with inactivated vaccine of Sinopharm Zhongsheng Beijing Company, Beijing Kexing Zhongwei Company, Sinopharm Zhongsheng Wuhan Company and adenovirus vector vaccine of Tianjin Kangxinuo Company for 6 months. Priority should be given to high-risk groups and infected people in key positions to ensure the basic operation of society. According to the needs of epidemic prevention and control, we will provide intensive immunization services for people aged 60 and above who are at high risk of serious diseases and those who need to be vaccinated.

For people who have completed two doses of basic immunization with inactivated vaccine produced by the same enterprise, in principle, inactivated vaccine produced by the same enterprise should be used for supplementary immunization; People who use inactivated vaccines produced by different companies to complete two doses of vaccination should, in principle, give priority to the second dose of vaccine produced by the same company to strengthen immunization. If there is no second vaccine from the same company, you can use the first vaccine from the same company. People who use adenovirus vector vaccine for basic immunization still use adenovirus vector vaccine for supplementary immunization.